{"podcast":{"title":"Hematologic Oncology Update","slug":"hematologic-oncology-update-916423","podcast_index_feed_id":916423,"rss_url":"https://feeds.captivate.fm/hematologic-oncology/","website_url":"https://www.researchtopractice.com/browse-tumor-types/hematologic-oncology","image_url":"https://artwork.captivate.fm/385e0bc2-3e77-4650-a103-033cd89470e0/VM1-kJu7V4rmiKPVI6DGtcq3.png","author":"Dr. Neil Love","episode_count":145,"summary":"Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.","last_synced_at":"2026-07-10T00:19:38.916639+00:00","page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423"},"episode":{"title":"Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances","slug":"bruton-tyrosine-kinase-inhibitors-for-chronic-lymphocytic-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances","published_at":"2026-05-23T13:00:00+00:00","page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423/bruton-tyrosine-kinase-inhibitors-for-chronic-lymphocytic-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances","show_page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423","url":"https://hematologic-oncology.captivate.fm/episode/5911-yir2025-btkicll","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/00efd3d7-e787-4962-bbe7-9e9fed73b00b.mp3","summary":"Dr Jennifer R Brown and Prof Wojciech Jurczak discuss the selection and sequencing of Bruton tyrosine kinase-targeted therapy for patients with chronic lymphocytic leukemia and summarize major advances in the treatment landscape over the past year. CME information and select publications here .","meta_description":"Dr Jennifer R Brown and Prof Wojciech Jurczak discuss the selection and sequencing of Bruton tyrosine kinase-targeted therapy for patients with chronic ly…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3522,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/bruton-tyrosine-kinase-inhibitors-for-chronic-lymphocytic-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hematologic-oncology-update-916423/bruton-tyrosine-kinase-inhibitors-for-chronic-lymphocytic-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}